The present invention relates to novel thienopyrimidine compounds of general formula
pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
本发明涉及一类新型的
噻吩并
嘧啶化合物,其具有通用公式[此处应有
化学结构公式],包括这些化合物的药物组合物及其用于预防或治疗可以通过抑制Mnk1和/或Mnk2(Mnk2a或Mnk2b)及其变体的激酶活性来影响的疾病的疗法。